Garodia Chemicals Q1 FY27 Net Loss of ₹0.10 Lakh

Key Decisions and Approvals

The Board meeting, which commenced at 01:00 P.M. and concluded at 01:40 P.M., approved the following items:

1. The Un-Audited Financial Results for the Quarter ended June 30, 2026, along with the draft Limited Review Report.

2. The appointment of Mrs. Sarita Subhash Salunkhe (DIN: 11684409) as an Additional, Non-Executive, Non-Independent Director of the Company, effective August 14, 2026. This appointment is liable for retirement by rotation and is subject to approval by shareholders at the ensuing general meeting.

3. The proposal to hold the Annual General Meeting (AGM) of the Company on Wednesday, September 30, 2026, at 04:00 P.M. through video conference mode, deemed to be held at the company's registered office.

Director Appointment Details (Annexure A)

A detailed disclosure pursuant to Regulation 30 was provided for the new director appointment:

Reason for Change: Appointment.
Date of Appointment: August 14, 2026.
Brief Profile: Mrs. Sarita Subhash Salunkhe has a broad understanding of general business and administrative matters. She is expected to contribute valuable insights and guidance as a Non-Executive Director.
Relationship with Directors: She is the mother of Mr. Ravi Salunkhe (Ravindra Subhash Salunkhe), the Managing Director of the Company.
Eligibility: She is not debarred from holding the office of director by virtue of any SEBI order or other authority.

Trading Window Closure

In view of the board meeting and results announcement, the Trading Window for designated persons and their immediate relatives was closed from July 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. This was in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code.

Unaudited Financial Results for Quarter Ended June 30, 2026 (Q1 FY27)

The financial results, prepared in accordance with Ind AS 34 and reviewed by the auditors, are presented below (Amounts in ₹ Lakhs):

| Revenue from operations | - | - | - |

| Other income | - | - | - |

| Total revenue | - | - | - |

| Employee benefits expense | 0.75 | 0.75 | 0.75 |

| Other expenses | 9.64 | 1.71 | 5.06 |

| Total expenses | 10.39 | 2.46 | 5.81 |

| Profit/(Loss) before tax | (10.39) | (2.46) | (5.81) |

| Tax expense | - | - | - |

| Profit/(Loss) for the period | (10.39) | (2.46) | (5.81) |

| Paid-up Equity Share Capital | 52.63 | 52.63 | 720.02 |

| Earnings Per Share (EPS) - Basic & Diluted | (1.97) | (0.22) | (0.08) |

Auditor's Review Report

Laxmikant Kabra & Co LLP (FRN: 117183W/W100736) issued a limited review report on the financial results. The report, signed by Partner CA Siddhant Kabra (M. No.: 193348) on August 14, 2026, stated that based on their review, nothing has come to their attention that causes them to believe the statement is not prepared properly.

Emphasis of Matter: The auditors included an emphasis paragraph noting that balances of Debtors, Creditors, Loans or Advances Given, and Loans or Advances Received are subject to confirmation and reconciliation.

Notes to Financial Results

1. The financial results were reviewed by the Audit Committee and approved by the Board of Directors on August 14, 2026.

2. The company operates a single business segment; therefore, segment reporting under Ind AS 108 is not applicable.

3. Previous quarter figures have been regrouped/reclassified where necessary for comparability.